PrintStock Updates|Stock Charts|NSE Market Tracker

We are committed to deliver long-term enrichment to our stakeholders

Since its inception in 1984, Dr. Reddy's has chosen to walk the path of discovery and innovation in health sciences. Ours has been a quest to sustain and improve the quality of life, and we have had nearly two decades of creating safe pharmaceutical solutions with the ultimate purpose of making the world a healthier place. Our competencies cover the entire pharmaceutical value chain – API and Intermediates, Finished Dosages (Branded and Generic) and NCE Research.

Our research centre uses cutting-edge technology and has discovered breakthrough pharmaceutical solutions in select therapeutic areas. In a short span of operations, we have filed for more than 75 patents. We are the first Indian company to out-license an NCE molecule for clinical trials. To strengthen our research arm, we have set up a research subsidiary, Reddy US Therapeutics Inc., in Atlanta, USA.

STOCK EXCHANGES

  • New York Stock Exchange (NYSE) (ADR listed)
  • National Stock Exchange (NSE)
  • Bombay Stock Exchange (BSE)

Shares are also traded in other stock exchanges as permitted securities. Options being traded on select international exchanges.

STOCK TICKERS

Bombay Stock Exchange
National Stock Exchange (NSE)
New York Stock Exchange (NYSE)
Reuters
Bloomberg
International Securities Identification Number (ISIN)
CUSIP number 500124
DRREDDY
RDY
REDY.BO
DRRD@IN
INE 089A01023
256135203
Top

  • Stock Charts